A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection OD

This study is comparing two different injectable medications for people with type 2 diabetes: GZR101 and GZR33-70, both given once daily. The goal is to see which version is more effective, better tolerated, and safer for managing blood sugar. **You may be eligible if...** - You are between 18 and 75 years old (male or female) - You have had a type 2 diabetes diagnosis for at least 6 months - You have signed the informed consent form **You may NOT be eligible if...** - You have a history of cancer - You have had a severe low blood sugar episode (Level 3) in the last 6 months - You were hospitalized for a heart attack, stroke, or severe heart failure in the last 6 months - You have participated in another clinical trial within the past 4 weeks - You have a known allergy to the study drugs Talk to your doctor to see if this trial is right for you.